To further elucidate the molecular mechanisms of combination strategy-triggered autophagic cell death, we explored whether the treatment could induce lung cancer cell autophagy through the inhibition of PI3K-AKT-mTOR signaling. This evidence concerns the gene AKT1 and lung cancer.